AAIPharma Inc. - Strategic SWOT Analysis Review by GlobalData

VIEWS: 40 PAGES: 16

AAIPharma Inc. - Strategic SWOT Analysis Review

Summary

AAIPharma Inc. (AAIPharma) is a privately held drug development company that is engaged in providing services to pharmaceutical, biotechnology and medical device companies. It provides a wide range of services from drug discovery to registering new drug product candidates. The services include analysis, testing, packing, and marketing new products. AAIPharma also provides services for infrastructure and clinical data management. It has many facilities in Europe and the U.S. In April 2009, the company entered into a strategic alliance with Emisphere Technologies, Inc. to expand the application of Eligen Technology and drug development services.

GlobalData’s AAIPharma Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important

More Info
									                            AAIPharma Inc. - Strategic SWOT Analysis Review

      Reference Code: GDPH26951SA                                                                                  Publication Date: DEC 2010

      2320 Scientific Park Drive             Phone      +1 800 5754224                         Revenue           NA
      Wilmington, NC                         Fax                                               Net Profit        NA
      28405                                  Website    www.aaipharma.com                      Employees         NA
      United States                          Exchange                                          Industry          Pharmaceuticals & Healthcare

      Company Overview
      AAIPharma Inc. (AAIPharma) is a privately held drug development company that is engaged in providing services to
      pharmaceutical, biotechnology and medical device companies. It provides a wide range of services from drug discovery to
      registering new drug product candidates. The services include analysis, testing, packing, and marketing new products.
      AAIPharma also provides services for infrastructure and clinical data management. It has many facilities in Europe and the U.S.
      In April 2009, the company entered into a strategic alliance with Emisphere Technologies, Inc. to expand the application of Eligen
      Technology and drug development services.

     Key Executives                                         SWOT Analysis
                Name                         Title          AAIPharma Inc., SWOT Analysis
      Jay Lifton                  Chairman                  Strengths                                  Weaknesses

      Ludo Reynders, Ph.D         Chief Executive Officer
                                                             Global Presence                            Limited Access Capital Markets
      Rebecca Pacholder           Director
      Christopher Kearns          Director                   Commitment to Quality
      Stuart Markowitz, M.D.      Director
      Source: Company Website, Primary and Secondary
      Research, GlobalData
                                                            Opportunities                              Threats

                                                             Health Care Reforms                        Competitive Pressures
     Key Competitors
      ImQuest BioSciences, Inc.                              Introduction of Xcelodose 600S             Competitive Pressures
                                                             System
      Cannabis Science, Inc.
      Danco Laboratories, LLC
      Nature Technology Corporation                          Source: Company Website, Primary and Secondary Research, GlobalData
     Strategic Health Resources
      Source: Company Website, Primary and Secondary
      Research, GlobalData




AAIPharma Inc. - Strategic SWOT Analysis Review                                                                             Reference Code: GDPH26951SA

Source : www.globalcompanyintelligence.com                                                                                                       Page 1
      Table of Contents
      Table of Contents........................................................................................................................................................................................................... 2
      List of Tables .................................................................................................................................................................................................................. 3
      Section 1 - About the Company ..................................................................................................................................................................................... 4
      AAIPharma Inc. - Key Facts ........................................................................................................................................................................................... 4
      AAIPharma Inc. - Key Employees.................................................................................................................................................................................. 5
      AAIPharma Inc. - Key Employee Biographies................................................................................................................................................................ 6
      AAIPharma Inc. - Major Products and Services............................................................................................................................................................. 7
      AAIPharma Inc. - History................................................................................................................................................................................................ 8
      AAIPharma Inc. - Company Statement .......................................................................................................................................................................... 9
      AAIPharma Inc. - Locations And Subsidiaries ............................................................................................................................................................. 10
            Head Office............................................................................................................................................................................................................ 10
            Other Locations & Subsidiaries ............................................................................................................................................................................. 10
      Section 2 – Company Analysis .................................................................................................................................................................................... 11
      AAIPharma Inc. - Business Description ....................................................................................................................................................................... 11
      AAIPharma Inc. - SWOT Analysis................................................................................................................................................................................ 12
            SWOT Analysis - Overview ................................................................................................................................................................................... 12
            AAIPharma Inc. - Strengths ................................................................................................................................................................................... 12
                  Strength - Global Presence............................................................................................................................................................................. 12
                  Strength - Commitment to Quality................................................................................................................................................................... 12
                  Strength - Broad Service Portfolio.................................................................................................................................................................. 12
            AAIPharma Inc. - Weaknesses.............................................................................................................................................................................. 13
                  Weakness - Limited Access Capital Markets .................................................................................................................................................. 13
            AAIPharma Inc. - Opportunities ............................................................................................................................................................................. 13
                  Opportunity - Health Care Reforms................................................................................................................................................................. 13
                  Opportunity - Introduction of Xcelodose 600S System ................................................................................................................................... 13
                  Opportunity - Strategic Alliances..................................................................................................................................................................... 13
                  Opportunity - Expansion of European Operations .......................................................................................................................................... 13
            AAIPharma Inc. - Threats ...............................................................................
								
To top